Inapsin en es it fr

Inapsin Brand names, Inapsin Analogs

Inapsin Brand Names Mixture

  • No information avaliable

Inapsin Chemical_Formula


Inapsin RX_link

Inapsin fda sheet

Inapsin msds (material safety sheet)

Inapsin MSDS

Inapsin Synthesis Reference

No information avaliable

Inapsin Molecular Weight

166.24 g/mol

Inapsin Melting Point

No information avaliable

Inapsin H2O Solubility

Appreciable as liquid hydrochloride salt

Inapsin State


Inapsin LogP


Inapsin Dosage Forms

Liquid for injection

Inapsin Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Inapsin Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Inapsin Absorption

Rapidly absorbed.

Inapsin side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Inapsin Patient Information

No information avaliable

Inapsin Organisms Affected

Humans and other mammals